Cytek Biosciences (CTKB) Inventory (2020 - 2026)

Cytek Biosciences' Inventory history runs 7 years deep, the most recent figure standing at $49.8 million for Q1 2026.

• Quarterly Inventory rose 9.8% year-over-year to $49.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $49.8 million (up 9.8% YoY) and the FY2025 annual result came in at $48.4 million, up 10.33% from the prior year.
• Inventory was $49.8 million for Q1 2026 at Cytek Biosciences, up from $48.4 million in the prior quarter.
• Across five years, Inventory topped out at $69.5 million in Q1 2023 and bottomed at $38.0 million in Q1 2022.
• A 5-year average of $52.0 million and a median of $49.5 million in 2025 frame the typical range for Inventory.
• Annual changes were most pronounced in 2023 — Inventory jumped 82.99% — and 2024, when it slumped 30.02%.
• Cytek Biosciences' Inventory stood at $48.2 million in 2022, then climbed by 26.42% to $60.9 million in 2023, then retreated by 27.9% to $43.9 million in 2024, then increased by 10.33% to $48.4 million in 2025, then increased by 2.81% to $49.8 million in 2026.
• Business Quant data shows CTKB's Inventory at $49.8 million in Q1 2026, $48.4 million in Q4 2025, and $51.6 million in Q3 2025.